Agios Pharmaceuticals | AGIO - Assets

Agios Pharmaceuticals reported $1.24B in Assets for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Assets Change
Agios Pharmaceuticals AGIO:US USD 1.24B 58.4M
Alnylam Pharmaceuticals ALNY:US USD 3.55B 11.1M
Amgen AMGN:US USD 65.12B 1.42B
Arrowhead Research ARWR:US USD 891.49M 199.55M
Astellas Pharma 4503:JP JPY 2.51T 69.71B
AstraZeneca AZN:LN USD 96.48B 2.3B
Bayer BAYN:GR EUR 124.88B 6.13B
Biogen BIIB:US USD 24.55B 300.1M
Biomarin Pharmaceutical BMRN:US USD 6.38B 111.03M
Bluebird Bio BLUE:US USD 520.1M 53.49M
Daiichi Sankyo 4568:JP JPY 2.4T 29.74B
Exelixis EXEL:US USD 3.07B 110.12M
Gilead Sciences GILD:US USD 63.17B 614M
GlaxoSmithKline GSK:LN GBP 60.15B 167M
Immunogen IMGN:US USD 348.94M 9.86M
IONIS PHARMACEUT IONS:US USD 2.53B 111.9M
JAZZ PHA JAZZ:US USD 10.84B 450.59M
Mirati Therapeutics MRTX:US USD 1.2B 100.44M
Moderna Inc MRNA:US USD 25.86B 198M
Nektar Therapeutics NKTR:US USD 710.6M 70.41M
Novartis NOVN:VX USD 117.45B 1.01B
Novartis NVS:US USD 117.45B 1.01B
Puma Biotechnology PBYI:US USD 222.06M 23.29M
Regeneron Pharmaceuticals REGN:US USD 29.21B 1.54B
Roche Holding ROG:VX 88.15B 1.42B
Sarepta Therapeutics SRPT:US USD 3.13B 27.78M
Seattle Genetics SGEN:US USD 3.67B 55.45M
Vertex Pharmaceuticals VRTX:US USD 18.15B 1.44B
YTE INCY:US USD 5.84B 330.77M